These results and data obtained from the sensitivity of v-Abl-accelerated plasma cell tumors and their phosphorylated STAT proteins to the effects of STI-571 indicate that these otherwise similar tumors utilize different signaling pathways but share a common initiating genetic lesion, a c-Myc-activating chromosome translocation. The gene discussed is ABL1; the disease is plasma cell neoplasm.